Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05525494 · ClinicalTrials.gov registry record · NA
Patient Portal Flu Vaccine Reminders (5)
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 262,085
- Enrollment target
NCT05525494 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 262,085 participants.
The verdict
NCT05525494, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 262,085 participants
- Enrollment target
Study Summary
This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. The study design is a 2x2 nested factorial design. Patients will be randomized into 1) receiving text based reminder messages with direct scheduling link, 2) portal-based reminder messages with direct scheduling link, or 3) the control group. Patients randomized to the intervention arms will receive reminders if they are due for influenza vaccine. Nested within the portal reminder arm, we will have two additional components for which patients will be randomized separately: 1. A pre-commitment prompt, asking patients which time (September, October, November or December) and which place (UCLA, pharmacy, workplace or school, or other) they plan to get their Influenza vaccine with tailored monthly messages based on responses (pre-commitment message with tailored recall messages with direct scheduling vs. standard portal reminders with direct scheduling). 2. A pre-appointment reminder encouraging patients to ask for their influenza vaccine at their upcoming appointment (pre-appointment reminder encouraging influenza vaccination vs. standard pre-appointment reminder not mentioning influenza vaccination) Nested within the text message reminder arm, we will have one additional component for which patients will be randomized separately: 1\) A pre-appointment reminder encouraging patients to ask for their influenza vaccine at their upcoming appointment (pre-appointment reminder encouraging influenza vaccination vs. standard pre-appointment reminder not mentioning influenza vaccination) Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and \>65 yrs. (63%). The investigators will assess the effectiveness of MyChart R/R messages and text R/R messages as compared to the standard of care
Interventions
- BEHAVIORAL Text Fixed R/R Messages with Direct Appointment Schedule Link
- BEHAVIORAL Text Pre-Appointment Reminder
- BEHAVIORAL Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link
- BEHAVIORAL Portal Fixed R/R Messages with Direct Appointment Schedule Link
- BEHAVIORAL Portal Pre-Appointment Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262,085 participants |
| Start Date | 2022-09-07 |
| Est. Completion | 2023-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05525494
The ClinicalTrials.gov registry entry for NCT05525494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 262,085 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Text Fixed R/R Messages with Direct Appointment Schedule Link is the first listed.
NCT05525494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05525494 about?
NCT05525494 is a clinical study titled "Patient Portal Flu Vaccine Reminders (5)". This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. The study design is a 2x2 nested factorial design. Patients will be randomized into 1) receiving text based reminder messages with direct scheduling link, 2) portal-based reminder messages with direct scheduling...
What is the current status of trial NCT05525494?
This trial is currently completed. It is a NA study. The enrollment target is 262,085 participants. The study started on 2022-09-07. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05525494?
The interventions under investigation include: Text Fixed R/R Messages with Direct Appointment Schedule Link (BEHAVIORAL), Text Pre-Appointment Reminder (BEHAVIORAL), Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link (BEHAVIORAL), Portal Fixed R/R Messages with Direct Appointment Schedule Link (BEHAVIORAL), Portal Pre-Appointment Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT05525494?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.